. Clinical characteristics of type 2 diabetic and normoglycemic patients. In the type 2 diabetic group, skin was obtained from leg amputates. Amputations were necessary because of severe vascular side effects of the diabetic condition. All patients had peripheral arterial occlusive disease (PAOD) and were treated because of hypertension. In the non-diabetic group, skin was taken from leg amputates (2 samples) and from abdominoplasty (2 samples). Only one of the patients had PAOD and was hypertensive. (*glycated haemoglobin in percent (% NGSP) and † in (mmol/mol) of total haemoglobin, ‡ body mass index, § peripheral arterial occlusive disease) Figure  2D . B: Taqman probes used for quantitative realtime PCR shown in Figure 3A .
A: Primers used for RT-PCR as described in {Wick, 2007 #90} 
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Supplementary Figure 1 . A: Dermal lymphatic capillaries show no differences in collagen IV deposition. Representative images of double immunofluorescence staining with anti-podoplanin and anti-collagen IV antibodies showed that lymphatic vessel basement membranes were weakly positive for collagen IV, but without significant expression differences between type 2 diabetic and non-diabetic lymphatic vessels. Podoplanin-negative blood capillaries showed strong collagen IV staining. Size bar = 20 µm. B: Dermal blood capillaries are specifically stained with DARC. Immunohistochemical stainings of consecutive human skin sections with anti-DARC and anti-CD31 antibodies show overlapping staining. Size bar = 100µm. Supplemental Table 4A . E: Quantitative realtime PCR analysis confirmed similar podoplanin expression levels in dLECs and ndLECs. Figure 3 . Ingenuity pathway analysis (IPA) results for dLEC transcripts enriched in annotated molecular and cellular functions. Rankings of the top ten Molecular and Cellular Functions most significant to the gene clusters "Inflammation and Wounding", "Lymph Vessel Remodeling and Growth" and "Small Molecule Biochemistry" in Table 1 . IPA software was used to calculate a P-value (set ≤ 0.05, shown as blue bars) by Fisher´s exact test, determining the probability with which a set of genes is associated with a known biological function. Categories are ranked according to the numbers of associated genes that are significantly enriched within them. The y-axis denotes the -log transformed Pvalue, denoting -log (0.05) = 1.3 as significance threshold (yellow line). Figure 4 . IPA results for dLEC transcripts enriched in annotated canonical pathways. For the canonical pathway categorization of all altered expressed genes, IPA software was used to calculate a P-value (set ≤ 0.05, shown as blue bars) by Fisher´s exact test, determining the probability with which a set of genes is associated with a known canonical pathway. The ratio (yellow squares) represents the number of differentially expressed genes from the dataset divided by the total number of genes that constitute that canonical pathway. Figure 8 . TNF-α induces CXCL10 protein expression and secretion by LECs. A: Immunoblot analysis and densitometric quantification of lysates from LECs treated under conditions shown below and transferred to nitrocellulose membranes, probed with anti-CXCL10 antibody, which reveals a 10kDa band. Blots were reprobed with anti-GAPDH antibodies as loading control. CXCL10 band densities were normalized to GAPDH levels (P-value = 0.007). Data are given as the mean ± S.D. of the experiment performed in triplicates. B: ELISA of LEC culture supernatants detecting enhanced levels of CXCL10 after stimulation with TNF-α (P-value = 0.06), which could be inhibited by TNF-α blocking antibody (P = 0.048). ELISA was performed according to standard protocol: After coating with concentrated LEC culture supernatants, wells were washed (PBS/0.1% tween-20), blocked with PBS/4% BSA and 100µl anti-CXCL10 antibody diluted in PBS/1%BSA was added. After incubation for 2 hours at room temperature, wells were washed three times and 100µl of peroxidase-coupled secondary antibody dilution was added for 1 hour at room temperature. After washing, color was developed for 20 minutes with 50µl substrate solution (3,3',5,5'-Tetramethylbenzidine Liquid Substrate, no.T4444, Sigma) under light protection. The reaction was stopped (TMB Substrate Stop Reagent, Sigma-Aldrich, no. S5814) and color absorbance was read at 450nm in a plate reader (Synergy HT; Bio-Tek) within 10 minutes.
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